NEJM study says Thoratec heart pump could increase rate of thrombosis A study published in the New England Journal of Medicine Wednesday stated, "We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. We investigated the occurrence of pump thrombosis and elevated lactate dehydrogenase levels, LDH levels presaging thrombosis, and outcomes of different management strategies in a multi-institutional study...The rate of pump thrombosis related to the use of the HeartMate II has been increasing at our centers and is associated with substantial morbidity and mortality." The HeartMate II is made by Thoratec. Reference Link
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.